+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Non-adherence to post-transplant care: prevalence, risk factors and outcomes in adolescent liver transplant recipients



Non-adherence to post-transplant care: prevalence, risk factors and outcomes in adolescent liver transplant recipients



Pediatric Transplantation 12(2): 194-200



This study examined the prevalence, demographic variables and adverse outcomes associated with non-adherence to post-transplant care in adolescent liver transplant recipients. We conducted a retrospective chart review of 111 adolescent patients (age 12-21 yr) greater than six months post-transplantation and defined non-adherence as not taking the immunosuppressive(s) or not attending any clinic visit in 2005. Fifty subjects (45.0%) were non-adherent and 61 (55.0%) were adherent. Twenty percent of the subjects did not attend clinic and 10.9% did not complete laboratory tests. Non-adherence was significantly associated with fewer completed laboratory tests (p < 0.0001), single parent status (p < 0.0186), and older age and greater years post-transplantation by both univariate and multivariate analyses (p < 0.008, p < 0.0141 and p < 0.0012, p < 0.0174, respectively). Non-adherence to medication was significantly associated with a rejection episode in 31 patients (p < 0.0069) but not in the subgroup of seven patients who stopped their immunosuppression completely. Non-adherence to post-transplant care is a prevalent problem in adolescents particularly of an older age and greater years post-transplantation. Rejection was a significant consequence of medication non-adherence except in a subgroup with presumed graft tolerance who discontinued their immunosuppression. These results emphasize the need for strict monitoring of adherence to post-transplant care to improve long-term survival and quality of life in adolescent transplant patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054637039

Download citation: RISBibTeXText

PMID: 18307668

DOI: 10.1111/j.1399-3046.2007.00809.x


Related references

Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort. Transplant Infectious Disease 20(1):, 2018

Pre-transplant risk factors predicting post-transplant cytomegalovirus infection in liver transplant recipients. Transplant International 20(5): 419-424, 2007

Pre-transplant history of mental health concerns, non-adherence, and post-transplant outcomes in kidney transplant recipients. Journal of Psychosomatic Research 105: 115-124, 2018

Pre-transplant history of mental health concerns, non-adherence, and post-transplant outcomes in kidney transplant recipients. Journal of Psychosomatic Research 105: 115-124, 2018

Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: The medication adherence in children who had a liver transplant cohort. Liver Transplantation 24(1): 80-88, 2018

Adolescent non-adherence: prevalence and consequences in liver transplant recipients. Pediatric Transplantation 10(3): 304-310, 2006

Post-transplant malignant neoplasia associated with cyclosporine-based immunotherapy: prevalence, risk factors and survival in feline renal transplant recipients. Veterinary and Comparative Oncology 14(4): E126-E134, 2016

Incidence and risk factors of EBV related post transplant lymphoproliferative diseases in paediatric liver transplant recipients treated with tacrolimus. Hepatology 26(4 Part 2): 343A, 1997

Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study. Bmc Nephrology 14: 261, 2013

The prevalence, risk factors, and outcomes of medication trade-offs in kidney and liver transplant recipients: a pilot study. Transplant International 31(8): 870-879, 2018

The use of objective case ascertainment to identify risk factors for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder in pediatric liver transplant recipients. Hepatology 36(4 Part 2): 662A, 2002

Sa1521 - Healthcare Utilization, Risk Factors, and Outcomes of Patients with Takotsubo Cardiomyopathy in Post-Liver Transplant Recipients. Gastroenterology 154(6): S-1142, 2018

Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases. Transplant Infectious Disease 7(3-4): 133-136, 2006

Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes. Bmc Nephrology 19(1): 332, 2018

Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest 123(3): 800-808, 2003